FEAF
TPEx

5321 美而快

57.00 ▲ 2.10 (3.83%) Close · 2026-11-13 · TPEx
Ask about 5321
This is research, not a buy or sell recommendation. Robo-advice in Taiwan requires an FSC licence; FEAF analyses, explains and monitors, and the investor makes the decision. Judgement thresholds are working rules pending review by the team's finance members.

Plain-language summary of valuation, growth, profitability, balance sheet, and recent MOPS filings.

Your risk profile
Conclusion

Mixed picture: 2 strengths against 3 watch-outs. Weigh them against your own goals.

Points to watch for a moderate profile: see the items marked above.

No model narrative: the model call failed. The structured analysis above is complete on its own.

Strengths

+ The current price implies -1.0% perpetual growth, within the 3.5% ceiling: expectations look attainable. source (Valuation) →
+ Free cash flow was positive in 2025: 193 NT$ million. source (Financials) →

Watch-outs

! Revenue fell -16.0% in 2025; latest quarter Q3 2026: 28.4% year on year. source (Financials) →
! Return on equity -9.5% with a -3.1% net margin: weak profitability. source (Key Stats) →
! Liabilities are 82.0% of total assets (Q3 2026): a heavy debt load. source (Financials) →

What to check before deciding

?Is the revenue decline temporary or structural?
?What would lift profitability, and how soon?
?Can operating cash cover the debt if conditions tighten?

What the analysis found

+ Valuation (DCF) The current price implies -1.0% perpetual growth, within the 3.5% ceiling: expectations look attainable. source →
! Growth Revenue fell -16.0% in 2025; latest quarter Q3 2026: 28.4% year on year. source →
! Profitability Return on equity -9.5% with a -3.1% net margin: weak profitability. source →
! Debt Liabilities are 82.0% of total assets (Q3 2026): a heavy debt load. source →
+ Cash flow Free cash flow was positive in 2025: 193 NT$ million. source →
· Filings 4 verified alert(s); latest on 2026-11-12: 代子公司維克樂公告新增資金貸與達公開發行公司資金貸與 及背書保證處理準則第二十二條第一項第二、三款公告 source →
· Filings 1 filing(s) are held or rejected and wait for human review. source →